Home
Features
Examples
Case Studies
Pricing
Support
Log In
Features
Examples
Case Studies
Pricing
Support
Log In
Create a Timeline Now
bluebird bio, Inc.
Print
Events
Genetix (est. 1992) become bluebird bio
September 2010
First transfusion-dependent β-thalassemia patient treated
May 2014
First sickle cell disease patient treated
October 2014
First multiple myeloma patient treated
February 2016
β-thalassemia drug receives PRIME status
September 2016
ADL treatment designated as Breakthrough Therapy
May 2018
EU marketing authorization for Zynteglo®
June 2019
Download Printable PDF
Paper Orientation
Landscape
Portrait
Paper Size
Normal Paper (8½" by 11")
Legal Paper (8½" by 14")
Stretch across multiple sheets of paper
Magnification
30%
40%
50%
60%
70%
80%
90%
100%
Download Now
Download Link
OK
OK
No
Yes